Rasagiline Withdrawal Syndrome in Parkinson’s Disease

Parkinson’s disease (PD) patients using dopamine agonists can develop withdrawal symptoms, referred to as dopamine agonist withdrawal syndrome (DAWS), under dose tapering or discontinuation of these drugs. DAWS includes a severe stereotypical cluster of psychiatric and psychological symptoms encompa...

Descripción completa

Detalles Bibliográficos
Autores principales: Solla, Paolo, Ercoli, Tommaso, Masala, Carla, Orofino, Gianni, Fadda, Laura, Corda, Davide Giacomo, Zarbo, Ignazio Roberto, Meloni, Mario, Sechi, Elia, Bagella, Caterina Francesca, Defazio, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870166/
https://www.ncbi.nlm.nih.gov/pubmed/35203982
http://dx.doi.org/10.3390/brainsci12020219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870166/
https://www.ncbi.nlm.nih.gov/pubmed/35203982
http://dx.doi.org/10.3390/brainsci12020219

Ejemplares similares